Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates

A single injection of ML29 reassortant vaccine for Lassa fever induces low, transient viremia, and low or moderate levels of ML29 replication in tissues of common marmosets depending on the dose of the vaccination. The vaccination elicits specific immune responses and completely protects marmosets a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lukashevich, Igor S., Carrion, Ricardo, Salvato, Maria S., Mansfield, Keith, Brasky, Kathleen, Zapata, Juan, Cairo, Cristiana, Goicochea, Marco, Hoosien, Gia E., Ticer, Anysha, Bryant, Joseph, Davis, Harry, Hammamieh, Rasha, Mayda, Maria, Jett, Marti, Patterson, Jean
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2582173/
https://ncbi.nlm.nih.gov/pubmed/18692539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.07.057
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires